Sotera Health Chairman and CEO Presents at 43rd Annual J.P. Morgan Healthcare Conference

Core Viewpoint - Sotera Health Company reported a strong performance in 2024, with expected revenues of approximately $1.1 billion, reflecting nearly 5% growth compared to 2023, indicating the resilience of its business model in various market conditions [2]. Company Overview - Sotera Health is a leading global provider of end-to-end sterilization solutions and lab testing and advisory services for the healthcare industry, operating through three main businesses: Sterigenics, Nordion, and Nelson Labs [6]. Financial Performance - The company anticipates full-year revenues of around$ 1.1 billion for 2024, which represents a growth of nearly 5% from 2023 and more than 5% growth on a constant currency basis [2]. - The financial results for the three months and year ended December 31, 2024, are still being finalized, and the actual results may vary from preliminary estimates [5]. Investor Engagement - The Chairman and CEO, Michael B. Petras, Jr., along with other executives, is participating in investor meetings at the 43rd Annual J.P. Morgan Healthcare Conference, with a live webcast of the presentation available on the company's website [2].